A PUTATIVE ROLE FOR BONE MORPHOGENETIC PROTEIN ANTAGONIST GREMLIN1 IN HER2 POSITIVE BREAST CANCERS

被引：0
|
作者：
Zabkiewicz, C. [1 ]
Ye, L. [1 ]
Hargest, R. [1 ]
机构：
[1] Cardiff Univ, Cardiff China Med Res Collaborat, Cardiff, S Glam, Wales
来源：
BRITISH JOURNAL OF SURGERY | 2019年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O17
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [41] JAM-A is over-expressed in aggressive Her2 positive breast cancers
    Brennan, K.
    Roche, T.
    McSherry, E. A.
    O'Grady, T.
    Kay, E. W.
    Hopkins, A. M.
    EJC SUPPLEMENTS, 2010, 8 (05): : 93 - 93
  • [42] Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression
    Elemam, Noha Mousaad
    Malek, Abdullah Imadeddin
    Mahmoud, Esraa Elaraby
    El-Huneidi, Waseem
    Talaat, Iman M.
    BIOMEDICINES, 2022, 10 (02)
  • [43] Intrinsic Bone Morphogenetic Protein Antagonist Gremlin 1 as a Potential Biomarker for Therapy Efficacy in a Rat Model of Pulmonary Arterial Hypertension
    Cantoni, S.
    Pastore, F.
    Schiavi, E.
    Cont, M.
    Pareti, S.
    Facchinetti, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] MicroRNAs as therapeutic and prognostic markers for resistance to therapy in HER2/neu positive breast cancers
    Mathranda, S. A.
    Diwakar, R. B.
    Srihari, S.
    Munirathnam, V.
    Simha, V.
    Anantharamu, S.
    Namani, A.
    Devi, D.
    Korlimarla, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1417 - S1417
  • [45] The survival of HER2 positive screen detected breast cancers in the abscence of chemotherapy and herceptin.
    Johnson, R. L.
    Prasad, R.
    Knox, W. F.
    Byrne, G.
    Morris, J.
    Cramer, A.
    Wilson, A.
    Bundred, N. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S110 - S111
  • [46] Are Thyroid Hormone and Tumor Cell Proliferation in Human Breast Cancers Positive for HER2 Associated?
    Mourouzis, Iordanis
    Tzovaras, Alexandros
    Armonis, Basil
    Ardavanis, Alexandros
    Skondra, Maria
    Misitzis, John
    Pectasides, Demetrios
    Pantos, Constantinos
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [47] THE ROLE OF STAR-D3 IN HER2 POSITIVE BREAST CANCER
    Mele, T.
    Gijsen, M.
    Ramachandran, A.
    Harris, A.
    Kong, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 31 - 31
  • [48] Prognostic role of plasma HER2 gene copy number in patients with HER2 positive metastatic breast cancer.
    Ran, Ran
    Huang, Wenfa
    Lin, Shao
    Niu, Yunyun
    Rugo, Hope S.
    Kong, Weiyao
    Bo, Shiping
    Lu, Sijia
    Li, Huiping
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Impacts of HER2 immunohistochemical scores on response and outcomes of HER2-positive breast cancers after neoadjuvant therapy
    Chiu, Yun-Ning
    Hsu, Chih-Yi
    Lien, Pei-Ju
    Chao, Ta-Chung
    Liu, Chun-Yu
    Lin, Yen-Shu
    Wang, Yu-Ling
    Tsai, Yi-Fang
    Tseng, Ling-Ming
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (04) : 409 - 417
  • [50] New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers
    N. Tchrakian
    L. Flanagan
    J. Harford
    J. M. Gannon
    C. M. Quinn
    Virchows Archiv, 2016, 468 : 207 - 211
12345